Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plasma EGFR Mutation-positive Lung Cancer”

3 trials

Showing 3 of 3 results

Testing effectiveness (Phase 2)UnknownNCT03346811
What this trial is testing

Efficiency of Icotinib in Plasma ctDNA EGFR Mutation-positive Patients Diagnosed With Lung Cancer

Who this might be right for
Plasma EGFR Mutation-positive Lung Cancer
Betta Pharmaceuticals Co., Ltd. 120
Not applicableUnknownNCT01776684
What this trial is testing

Evaluation of EGFR TKI Resistance Mechanism Using Plasma DNA Analysis

Who this might be right for
EGFR Mutation Positive Non-small Cell Lung Cancer
Samsung Medical Center 200
Large-scale testing (Phase 3)Study completedNCT02997501
What this trial is testing

T790M Plasma Testing Methodology Comparison and Clinical Validation

Who this might be right for
Lung Cancer
AstraZeneca 256

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation